Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma)
Middle East Pharmaceutical Industries Co. (Avalon Pharma) shareholders authorized the board of directors to distribute interim dividends to shareholders semi-annually or quarterly for 2024.
The decision was taken during the extraordinary general meeting (EGM) held on June 30, the company said in a statement on Tadawul.
In addition, shareholders approved to discharge board members from liability for the year ended on Dec. 31, 2023, the statement added.
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}